Cost-Effectiveness Analysis of Umeclidinium Bromide/Vilanterol 62.5/25 MCG Versus Tiotropium/Olodaterol 5/5 MCG in Symptomatic Patients with Chronic Obstructive Pulmonary Disease in Spain
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1583
https://www.valueinhealthjournal.com/article/S1098-3015(18)31889-8/fulltext
Title :
Cost-Effectiveness Analysis of Umeclidinium Bromide/Vilanterol 62.5/25 MCG Versus Tiotropium/Olodaterol 5/5 MCG in Symptomatic Patients with Chronic Obstructive Pulmonary Disease in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31889-8&doi=10.1016/j.jval.2018.04.1583
First page :
Section Title :
Open access? :
No
Section Order :
811